White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of MK-1200 for Patients with Advanced Solid Tumors

Not recruiting

1 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
- Mk-1200
Study Comparing Human Normal Immunoglobulin and Placebo for Children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)

Not recruiting

3 1 1
Investigated diseases:
- Paediatric acute-onset neuropsychiatric syndrome
Investigated drugs:
- Human Normal Immunoglobulin
Study of dasatinib treatment in children and adolescents with Philadelphia chromosome-positive leukemia who cannot take imatinib or for whom imatinib is not effective

Not recruiting

1 1 1
Investigated diseases:
- Leukaemia
- Philadelphia chromosome positive
Investigated drugs:
- Dasatinib
Study on Long-Term Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

Not recruiting

3 1 1
Investigated diseases:
- Fragile X syndrome
Investigated drugs:
- Cannabidiol
Study on L19TNF and Doxorubicin for Patients with Advanced or Metastatic Soft Tissue Sarcoma

Not recruiting

3 1 1 1
Investigated diseases:
- Soft tissue sarcoma
Investigated drugs:
- Doxorubicin Hydrochloride
- Onfekafusp Alfa
Study on TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for or Refusing Platinum-Based Chemotherapy

Not recruiting

2 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
- Cetrelimab
- Gemcitabine Hydrochloride
Study to Determine the Best Dose of Vesleteplirsen for Patients with Duchenne Muscular Dystrophy Suitable for Exon 51-Skipping Treatment

Not recruiting

2 1 1
Investigated drugs:
- Vesleteplirsen
Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
Study on the Safety and Effectiveness of Amivantamab and Capmatinib for Patients with Unresectable Metastatic Non-Small Cell Lung Cancer

Not recruiting

1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Amivantamab
- Capmatinib
Study on Latent Autoimmune Diabetes in Adults (LADA) Patients: Evaluating Diabetes Status 3 Years After Treatment with Glutamate Decarboxylase 2

Not recruiting

2 1 1
Investigated diseases:
- Latent autoimmune diabetes in adults
Investigated drugs:
- Glutamate Decarboxylase 2, Human, Recombinant

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies